Rosiglitazone Improves Exercise Capacity in Individuals With Type 2 Diabetes

Abstract

This is the first known report showing that a TZD improved exercise function in type 2 diabetes. Whether this is due to the observed improvements in insulin sensitivity and/or endothelial function or to another action of the TZD class requires further exploration.